Literature DB >> 24192268

Ex-vivo whole blood secretion of interferon (IFN)-γ and IFN-γ-inducible protein-10 measured by enzyme-linked immunosorbent assay are as sensitive as IFN-γ enzyme-linked immunospot for the detection of gluten-reactive T cells in human leucocyte antigen (HLA)-DQ2·5(+) -associated coeliac disease.

N Ontiveros1, J A Tye-Din, M Y Hardy, R P Anderson.   

Abstract

T cell cytokine release assays are used to diagnose infectious diseases, but not autoimmune or allergic disease. Coeliac disease (CD) is a common T cell-mediated disease diagnosed by the presence of gluten-dependent intestinal inflammation and serology. Many patients cannot be diagnosed with CD because they reduce dietary gluten before medical workup. Oral gluten challenge in CD patients treated with gluten-free diet (GFD) mobilizes gluten-reactive T cells measurable by interferon (IFN)-γ enzyme-linked immunospot (ELISPOT) or major histocompatibility complex (MHC) class II tetramers. Immunodominant peptides are quite consistent in the 90% of patients who possess HLA-DQ2·5. We aimed to develop whole blood assays to detect gluten-specific T cells. Blood was collected before and after gluten challenge from GFD donors confirmed to have CD (n = 27, all HLA-DQ2·5(+) ), GFD donors confirmed not to have CD (n = 6 HLA-DQ2·5(+) , 11 HLA-DQ2·5(-) ) and donors with CD not following GFD (n = 4, all HLA-DQ2·5(+) ). Plasma IFN-γ and IFN-γ inducible protein-10 (IP-10) were measured by enzyme-linked immunosorbent assay (ELISA) after whole blood incubation with peptides or gliadin, and correlated with IFN-γ ELISPOT. No T cell assay could distinguish between CD patients and controls prior to gluten challenge, but after gluten challenge the whole blood IFN-γ ELISA and the ELISPOT were both 85% sensitive and 100% specific for HLA-DQ2·5(+) CD patients; the whole blood IP-10 ELISA was 94% sensitive and 100% specific. We conclude that whole blood cytokine release assays are sensitive and specific for detection of gluten-reactive T cells in CD; further clinical studies addressing the utility of these tests in patients with an uncertain diagnosis of CD is warranted.
© 2013 British Society for Immunology.

Entities:  

Keywords:  coeliac disease; diagnostics; gluten challenge

Mesh:

Substances:

Year:  2014        PMID: 24192268      PMCID: PMC3892421          DOI: 10.1111/cei.12232

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10.

Authors:  L A van Pinxteren; P Ravn; E M Agger; J Pollock; P Andersen
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

Review 2.  Harmonization of immune biomarker assays for clinical studies.

Authors:  Sjoerd H van der Burg; Michael Kalos; Cécile Gouttefangeas; Sylvia Janetzki; Christian Ottensmeier; Marij J P Welters; Pedro Romero; Cedrik M Britten; Axel Hoos
Journal:  Sci Transl Med       Date:  2011-11-09       Impact factor: 17.956

3.  The impact of harmonization on ELISPOT assay performance.

Authors:  Sylvia Janetzki; Cedrik M Britten
Journal:  Methods Mol Biol       Date:  2012

4.  Short wheat challenge is a reproducible in-vivo assay to detect immune response to gluten.

Authors:  A Camarca; G Radano; R Di Mase; G Terrone; F Maurano; S Auricchio; R Troncone; L Greco; C Gianfrani
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

Review 5.  Recent advances in diagnostic technology: applications in autoimmune and infectious diseases.

Authors:  A Lalvani; P L Meroni; K A Millington; M L Modolo; M Plebani; A Tincani; D Villalta; A Doria; A Ghirardello
Journal:  Clin Exp Rheumatol       Date:  2008 Jan-Feb       Impact factor: 4.473

6.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

7.  Dietary gluten triggers concomitant activation of CD4+ and CD8+ αβ T cells and γδ T cells in celiac disease.

Authors:  Arnold Han; Evan W Newell; Jacob Glanville; Nielsen Fernandez-Becker; Chaitan Khosla; Yueh-Hsiu Chien; Mark M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

8.  Diagnosis of celiac disease in adults based on serology test results, without small-bowel biopsy.

Authors:  Jamile' Wakim-Fleming; Mangesh R Pagadala; Martin S Lemyre; Rocio Lopez; Arthi Kumaravel; William D Carey; Nizar N Zein
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-07       Impact factor: 11.382

Review 9.  Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules.

Authors:  Ludvig M Sollid; Shuo-Wang Qiao; Robert P Anderson; Carmen Gianfrani; Frits Koning
Journal:  Immunogenetics       Date:  2012-02-10       Impact factor: 2.846

10.  A novel serogenetic approach determines the community prevalence of celiac disease and informs improved diagnostic pathways.

Authors:  Robert P Anderson; Margaret J Henry; Roberta Taylor; Emma L Duncan; Patrick Danoy; Marylia J Costa; Kathryn Addison; Jason A Tye-Din; Mark A Kotowicz; Ross E Knight; Wendy Pollock; Geoffrey C Nicholson; Ban-Hock Toh; Matthew A Brown; Julie A Pasco
Journal:  BMC Med       Date:  2013-08-28       Impact factor: 8.775

View more
  23 in total

Review 1.  Celiac disease: from etiological factors to evolving diagnostic approaches.

Authors:  Anantdeep Kaur; Olga Shimoni; Michael Wallach
Journal:  J Gastroenterol       Date:  2017-06-19       Impact factor: 7.527

2.  Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies.

Authors:  Gautam Goel; Tim King; A James Daveson; Jane M Andrews; Janakan Krishnarajah; Richard Krause; Gregor J E Brown; Ronald Fogel; Charles F Barish; Roger Epstein; Timothy P Kinney; Philip B Miner; Jason A Tye-Din; Adam Girardin; Juha Taavela; Alina Popp; John Sidney; Markku Mäki; Kaela E Goldstein; Patrick H Griffin; Suyue Wang; John L Dzuris; Leslie J Williams; Alessandro Sette; Ramnik J Xavier; Ludvig M Sollid; Bana Jabri; Robert P Anderson
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-05-11

3.  Serum cytokines elevated during gluten-mediated cytokine release in coeliac disease.

Authors:  G Goel; A J M Daveson; C E Hooi; J A Tye-Din; S Wang; E Szymczak; L J Williams; J L Dzuris; K M Neff; K E Truitt; R P Anderson
Journal:  Clin Exp Immunol       Date:  2019-10-01       Impact factor: 4.330

4.  Evaluating Responses to Gluten Challenge: A Randomized, Double-Blind, 2-Dose Gluten Challenge Trial.

Authors:  Maureen M Leonard; Jocelyn A Silvester; Daniel Leffler; Alessio Fasano; Ciarán P Kelly; Suzanne K Lewis; Jeffrey D Goldsmith; Elliot Greenblatt; William W Kwok; William J McAuliffe; Kevin Galinsky; Jenifer Siegelman; I-Ting Chow; John A Wagner; Anna Sapone; Glennda Smithson
Journal:  Gastroenterology       Date:  2020-10-29       Impact factor: 22.682

5.  Whole blood interleukin-2 release test to detect and characterize rare circulating gluten-specific T cell responses in coeliac disease.

Authors:  R P Anderson; G Goel; M Y Hardy; A K Russell; S Wang; E Szymczak; R Zhang; K E Goldstein; K Neff; K E Truitt; L J Williams; J L Dzuris; J A Tye-Din
Journal:  Clin Exp Immunol       Date:  2021-02-28       Impact factor: 5.732

Review 6.  Assessing of Celiac Disease and Nonceliac Gluten Sensitivity.

Authors:  N Ontiveros; M Y Hardy; F Cabrera-Chavez
Journal:  Gastroenterol Res Pract       Date:  2015-04-29       Impact factor: 2.260

7.  Self-Reported Prevalence of Symptomatic Adverse Reactions to Gluten and Adherence to Gluten-Free Diet in an Adult Mexican Population.

Authors:  Noe Ontiveros; Jesús A López-Gallardo; Marcela J Vergara-Jiménez; Francisco Cabrera-Chávez
Journal:  Nutrients       Date:  2015-07-21       Impact factor: 5.717

Review 8.  Development of drugs for celiac disease: review of endpoints for Phase 2 and 3 trials.

Authors:  Klaus Gottlieb; Jill Dawson; Fez Hussain; Joseph A Murray
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-02-26

9.  A Sensitive Whole Blood Assay Detects Antigen-Stimulated Cytokine Release From CD4+ T Cells and Facilitates Immunomonitoring in a Phase 2 Clinical Trial of Nexvax2 in Coeliac Disease.

Authors:  Melinda Y Hardy; Gautam Goel; Amy K Russell; Swee Lin G Chen Yi Mei; Gregor J E Brown; Suyue Wang; Evan Szymczak; Ruan Zhang; Kaela E Goldstein; Kristin M Neff; Leslie J Williams; Kenneth E Truitt; John L Dzuris; Jason A Tye-Din; Robert P Anderson
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

Review 10.  Non-Celiac Gluten Sensitivity: An Update.

Authors:  Feliznando Isidro Cárdenas-Torres; Francisco Cabrera-Chávez; Oscar Gerardo Figueroa-Salcido; Noé Ontiveros
Journal:  Medicina (Kaunas)       Date:  2021-05-24       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.